ST-Segment Resolution and Outcome in Myocardial Infarction

Journal of the American College of Cardiology

Volumn 55, Issue 15, 2010, Pages 1646-1647

  Buller, Christopher E ^a   Westerhout, Cynthia M ^a   Armstrong, Paul W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; MONOCLONAL ANTIBODY; PEXILIZUMAB; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; CLINICAL PRACTICE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; HUMAN; LETTER; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; SURVIVAL RATE;

CORONARY CIRCULATION; DENMARK; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOVERY OF FUNCTION; SURVIVAL RATE;

EID: 77950322409     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.033     Document Type: Letter

References (3)

1. Sejersten M., Valeur N., Grande P., Nielsen T.T., Clemmensen P., and DANAMI-2 Investigators. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention: results from the DANAMI-2. J Am Coll Cardiol 54 (2009) 1763-1769
2. McLaughlin M.G., Stone G.W., Aymong E., et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004) 1215-1223
3. Buller C.E., Fu Y., Mahaffey K.W., et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial. Circulation 118 (2008) 1335-1346